BellPIC study: A randomised, triple blinded, placebo controlled trial for the use of prednisolone to improve recovery from Bell’s palsy at 1 month.
Recruitment finished September 1st 2020.
Since commencement of recruitment in 2015 at 10 hospitals within the Australian and New Zealand PREDICT research network, we have randomised 186 participants aged between 6 months and 18 years of age.
A HUGE thank you to all the sites who have dedicated their time and expertise to contributing to this fantastic recruitment number and data collection. With this large multicentre randomised trial, it will allow the definitive assessment of the efficacy of prednisolone compared with placebo in the treatment of Bell’s palsy in children.
Data cleaning is underway by the RCH Research Trial Co-ordinator, with participant follow up continuing until March 2021 and data analysis to be performed mid-2021.
Watch this space!